Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons

Tau, as a microtubule (MT)-associated protein, participates in key neuronal functions such as the regulation of MT dynamics, axonal transport, and neurite outgrowth. Alternative splicing of exon 10 in the tau primary transcript gives rise to protein isoforms with three (3R) or four (4R) MT binding repeats. Although tau isoforms are balanced in the normal adult human brain, imbalances in 3R:4R ratio have been tightly associated with the pathogenesis of several neurodegenerative disorders, yet the underlying molecular mechanisms remain elusive. Several studies exploiting tau overexpression and/or mutations suggested that perturbations in tau metabolism impair axonal transport. Nevertheless, no physiological model has yet demonstrated the consequences of altering the endogenous relative content of tau isoforms over axonal transport regulation. Here, we addressed this issue using a trans-splicing strategy that allows modulating tau exon 10 inclusion/exclusion in differentiated human-derived neurons. Upon changes in 3R:4R tau relative content, neurons showed no morphological changes, but live imaging studies revealed that the dynamics of the amyloid precursor protein (APP) were significantly impaired. Single trajectory analyses of the moving vesicles showed that predominance of 3R tau favored the anterograde movement of APP vesicles, increasing anterograde run lengths and reducing retrograde runs and segmental velocities. Conversely, the imbalance toward the 4R isoform promoted a retrograde bias by a significant reduction of anterograde velocities. These findings suggest that changes in 3R:4R tau ratio has an impact on the regulation of axonal transport and specifically in APP dynamics, which might link tau isoform imbalances with APP abnormal metabolism in neurodegenerative processes. SIGNIFICANCE STATEMENT The tau protein has a relevant role in the transport of cargos throughout neurons. Dysfunction in tau metabolism underlies several neurological disorders leading to dementia. In the adult human brain, two tau isoforms are found in equal amounts, whereas changes in such equilibrium have been associated with neurodegenerative diseases. We investigated the role of tau in human neurons in culture and found that perturbations in the endogenous balance of tau isoforms were sufficient to impair the transport of the Alzheimer's disease-related amyloid precursor protein (APP), although neuronal morphology was normal. Our results provide evidence of a direct relationship between tau isoform imbalance and defects in axonal transport, which induce an abnormal APP metabolism with important implications in neurodegeneration.

[1]  L. Bodea,et al.  Tau physiology and pathomechanisms in frontotemporal lobar degeneration , 2016, Journal of neurochemistry.

[2]  D. Hanger,et al.  Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons , 2016, Neurobiology of Disease.

[3]  Daniel J. Gaffney,et al.  Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations , 2015, Brain : a journal of neurology.

[4]  Keith A. Johnson,et al.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging , 2015, Neuropathology and applied neurobiology.

[5]  L. Goldstein,et al.  Biophysical challenges to axonal transport: motor-cargo deficiencies and neurodegeneration. , 2014, Annual review of biophysics.

[6]  E. Teng,et al.  Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with Aging , 2014, The Journal of Neuroscience.

[7]  L. Goldstein,et al.  Fast axonal transport of the proteasome complex depends on membrane interaction and molecular motor function , 2014, Journal of Cell Science.

[8]  Andrew R. Thompson,et al.  Tau interconverts between diffusive and stable populations on the microtubule surface in an isoform and lattice specific manner , 2014, Cytoskeleton.

[9]  T. Révész,et al.  The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons , 2013, Acta Neuropathologica.

[10]  R. Crowther,et al.  Tau Pathology is Present In Vivo and Develops In Vitro in Sensory Neurons from Human P301S Tau Transgenic Mice: A System for Screening Drugs against Tauopathies , 2013, The Journal of Neuroscience.

[11]  E. Holzbaur,et al.  JIP1 regulates the directionality of APP axonal transport by coordinating kinesin and dynein motors , 2013, The Journal of cell biology.

[12]  M. C. Tarhan,et al.  Biosensing MAPs as "roadblocks": kinesin-based functional analysis of tau protein isoforms and mutants using suspended microtubules (sMTs). , 2013, Lab on a chip.

[13]  Michel Goedert,et al.  Tau pathology and neurodegeneration , 2013, The Lancet Neurology.

[14]  J. Mertens,et al.  Embryonic stem cell-based modeling of tau pathology in human neurons. , 2013, The American journal of pathology.

[15]  J. Gallo,et al.  Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing , 2013, Human molecular genetics.

[16]  L. Goldstein Axonal transport and neurodegenerative disease: Can we see the elephant? , 2012, Progress in Neurobiology.

[17]  Adam G. Hendricks,et al.  Force measurements on cargoes in living cells reveal collective dynamics of microtubule motors , 2012, Proceedings of the National Academy of Sciences.

[18]  C. Leidel,et al.  Measuring molecular motor forces in vivo: implications for tug-of-war models of bidirectional transport. , 2012, Biophysical journal.

[19]  A. Ittner,et al.  Lessons from Tau-Deficient Mice , 2012, International journal of Alzheimer's disease.

[20]  Gaudenz Danuser,et al.  Molecular motor function in axonal transport in vivo probed by genetic and computational analysis in Drosophila , 2012, Molecular biology of the cell.

[21]  M. Goedert,et al.  Reduced Axonal Transport and Increased Excitotoxic Retinal Ganglion Cell Degeneration in Mice Transgenic for Human Mutant P301S Tau , 2012, PloS one.

[22]  A. Andreadis,et al.  Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport , 2012, Neurobiology of Aging.

[23]  Derrick P. McVicker,et al.  The Nucleotide-binding State of Microtubules Modulates Kinesin Processivity and the Ability of Tau to Inhibit Kinesin-mediated Transport* , 2011, The Journal of Biological Chemistry.

[24]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[25]  N. Hirokawa,et al.  Kinesin‐1/Hsc70‐dependent mechanism of slow axonal transport and its relation to fast axonal transport , 2010, The EMBO journal.

[26]  M. Garcia-Blanco,et al.  Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing , 2009, Human molecular genetics.

[27]  Concepción Lillo,et al.  Axonal Stress Kinase Activation and Tau Misbehavior Induced by Kinesin-1 Transport Defects , 2009, The Journal of Neuroscience.

[28]  Jürgen Götz,et al.  Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia , 2008, Proceedings of the National Academy of Sciences.

[29]  A. Grierson,et al.  Role of axonal transport in neurodegenerative diseases. , 2008, Annual review of neuroscience.

[30]  Melanie J. I. Müller,et al.  Tug-of-war as a cooperative mechanism for bidirectional cargo transport by molecular motors , 2008, Proceedings of the National Academy of Sciences.

[31]  Ram Dixit,et al.  Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.

[32]  Aidong Yuan,et al.  Axonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice , 2008, The Journal of Neuroscience.

[33]  M. Goedert,et al.  Interaction of tau protein with the dynactin complex , 2007, The EMBO journal.

[34]  M. Vitek,et al.  The Tau N279K Exon 10 Splicing Mutation Recapitulates Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Tauopathy in a Mouse Model , 2007, The Journal of Neuroscience.

[35]  E. Mandelkow,et al.  Quantification of Amyloid Precursor Protein and Tau for the Study of Axonal Traffic Pathways , 2007, The Journal of Neuroscience.

[36]  B. C. Carter,et al.  Multiple-motor based transport and its regulation by Tau , 2007, Proceedings of the National Academy of Sciences.

[37]  J. Götz,et al.  Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? , 2006, Journal of neurochemistry.

[38]  M. Garcia-Blanco,et al.  Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: Implications for tauopathies , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[40]  A. Andreadis Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. , 2005, Biochimica et biophysica acta.

[41]  Leslie Wilson,et al.  Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[43]  E. Mandelkow,et al.  Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. , 1999, Journal of cell science.

[44]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[45]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[47]  D. Price,et al.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[49]  Takahiro Sasaki,et al.  Global axonal transport rates are unaltered in htau mice in vivo. , 2013, Journal of Alzheimer's disease : JAD.

[50]  G. Stokin,et al.  Imaging amyloid precursor protein in vivo: an axonal transport assay. , 2012, Methods in molecular biology.

[51]  Xiaoqing Zhang,et al.  Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells. , 2010, Methods in molecular biology.